FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TOCILIZUMAB
异名/同义词ACTEMRA
ATLIZUMAB
BAT1806
BAT-1806
BIIB800
BIIB-800
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
MRA
MSB11456
MSB-11456
R-1569
RG-1569
RGB19
RGB-19
RHPM-1
RO-4877533
ROACTEMRA
TOCILIZUMAB
TOCILIZUMAB (GENETICAL RECOMBINATION)
TOCILIZUMAB [EMA EPAR]
TOCILIZUMAB [INN]
TOCILIZUMAB [JAN]
TOCILIZUMAB [MART.]
TOCILIZUMAB [MI]
TOCILIZUMAB [PURPLE BOOK CDER]
TOCILIZUMAB [USAN]
TOCILIZUMAB [VANDF]
TOCILIZUMAB [WHO-DD]
TOCILIZUMAB BIOSIMILAR (BAT-1806)
TOCILIZUMAB BIOSIMILAR (MSB11456)
TOCILIZUMAB BIOSIMILAR (RGB-19)
TOCILIZUMAB-AAZG
TOCILIZUMAB-BAVI
TOFIDENCE
TYENNE
CAS登记号375823-41-9
物质唯一标识(Unique Ingredient Identifier)I031V2H011
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System